What's breaking now, across thousands of outlets.
(RTTNews) - Natera, Inc. (NTRA) announced that its Signatera test has received regulatory approval from Japan's Pharmaceuticals and Medical Devices Agency as a companion diagnostic in muscle-invasive bladder cancer. The approval supports the use of the Signatera test to guide ad
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Thousands of patients awaiting sight-saving surgery in Gaza could be in line for urgent eye care with the latest humanitarian aid drop due to arrive from the UAE.
President John Dramani Mahama will in the coming weeks cut sod for the construction of three 160-bed Regional Referral Hospitals in the Oti, Savannah and Western North Regions, Government…
AngloGold Ashanti (AGA) Obuasi Mine has intensified efforts to promote inclusion and reduce stigma surrounding autism and other developmental conditions through a two-day awareness and capacity-building programme for teachers, parents, caregivers and community members.
Health professionals are urging parents and caregivers to seek early medical attention whenever they notice unusual symptoms in their children.
